You searched for "procedures"

5643 results found

Ireland urged to demonstrate leadership with binding commitments on global eye health ahead of 2026 summit

CBM Ireland has urged Governments to make clear, funded commitments on global eye health ahead of a pivotal international summit later this year, warning that avoidable blindness persists not for lack of solutions, but for lack of political and financial...

SeeAbility achieves Guinness World Records title

SeeAbility achieves Guinness World Records title to highlight the tens of thousands of children with learning disabilities and autism missing out on basic eye care. National charity SeeAbility has achieved a huge GUINNESS WORLD RECORDS title for: “Most participants featured...

The International AMD Genomics Consortium study: another success in understanding the complex genetics of AMD

Age-related macular degeneration (AMD) is a neurodegenerative complex disease of the eye and a major cause of blindness and visual impairment among the elderly worldwide. The early stages of the disease are characterised by asymptomatic pigmentary abnormalities and accumulation of...

Breakthroughs in the genetics of angle-closure glaucoma

Angle closure glaucoma (ACG) is not widely known to be a familial condition, yet the recent explosion of genetic data and large scale genome wide investigations have confirmed at least 13 genetic loci associated with ACG [1], and provided some...

Strategies for managing neovascular AMD and DMO in routine clinical care

Treatment practice in the management of neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DMO) illustrate increasing adoption of patient-tailored treatment approaches based on initial diagnosis and regular monitoring of imaging and visual outcomes in routine clinical care. The...

Genetic profiling for personalised healthcare solutions in AMD – an update

Age-related macular degeneration (AMD) is a multifactorial condition influenced by genetics and lifestyle factors (Table 1). This article outlines several recent advances in AMD genetics, as well as evolving therapeutic concepts and established practical measures for the treatment and /...

NICE drugs: an update on what’s good to go

Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...

Contemporary glaucoma therapy: spoilt for choice

The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...

SILMO 2019: Anything goes, but sustainability grows

Trying to spot the trends at this year’s SILMO in Paris, one of the largest optical fairs in the world, was a tough ask. Thin metals, especially in rose gold, abounded, but that’s now; tomorrow remained elusive.

Lancet Commission calls for global action on blindness

The Lancet Global Health Commission on Global Eye Health highlights the changing nature of the issues facing eye health professionals worldwide.

OAEE UPDATE - Urgent Call for Surgical Supplies in Ukraine

UK professionals have called for aid in sending surgical equipment to Ukraine during Russian invasion.

Women-led, solar powered eye centres to treat 1 million people at risk of avoidable blindness in India

One million people at risk of avoidable blindness in West Bengal, India, now have access to eye care thanks to the opening of nine environmentally friendly Green Vision Centres, five of which are led by women.